.png)
Sacral Nerve Stimulation Market by Product and Application - Global Industry Analysis and Forecast to 2027
Published On : September 2017 Pages : 80 Category: Medical Devices Report Code : HC06144
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Industry Trend Analysis
The global sacral nerve stimulation (SNS) market is expected to be around $3.3 billion by 2027. The market is primarily driven by factors such as increasing incidence of neurological disorders around the world, rising geriatric population along with increase in the investment for development of sacral nerve stimulation products by the key players in the market. Moreover, increase in the number of patients suffering from overactive bladder (OAB) condition is also expected to largely contribute to the market growth over the forecast period. However, factors such as unfavorable reimbursement policies and side-effects associated with SNS devices can hinder the market growth during the forecast period.
Product Outlook and Trend Analysis
The sacral nerve stimulator device is implanted under the skin specifically in the upper buttock area. The device consists of an implantable pulse generator. A lead is positioned near the sacral nerve in the lower back through which, a mild electric impulse is delivered which can positively influence the pelvic floor muscles and the rectal sphincters. Before the implantation of the permanent device, patients usually undergo a test to analyze the impact of nerve stimulation in terms of potential response from the patients. The observations from the test are analyzed to determine whether the patient is an appropriate candidate for implanting the permanent device. Implantable SNS devices segment held a significant share of the overall market in 2017 owing to their widespread applications for conditions such as fecal and urine incontinence.
Application Outlook and Trend Analysis
Urine incontinence refers to the accidental leakage of urine. Such leakage can occur when there is a sudden urge to urinate and the person is unable to control the urge in time. By delivering a mild electric impulse to the pelvic muscles or nerves situated in the lower back which are involved in urination, urinary incontinence can be effectively treated. Sacral nerve stimulation has emerged as a relatively new approach for treating fecal incontinence. The stimulator influences the muscles that control the anus and the bowel in order to efficiently manage the passage of stool from the body.
Regional Outlook and Trend Analysis
North America held a significant share of the global sacral nerve stimulation market in 2017 owing to large scale adoption of SNS devices to treat patient affected by incontinence. The emerging markets in the Asia-Pacific region are expected to witness favorable growth during the forecast due to the presence of unmet medical needs of the population in the region along with increasing disposable income.
Competitive Analysis
The key players operating in the global sacral nerve stimulation market focus on product development and approvals in order to introduce advanced SNS solutions for effectively treating patients suffering from incontinence and secure a larger share of the global market. For instance, in February 2022, Nuvectra Corporation filed regulatory submission with the FDA in the U.S. and with the CE Mark authorities in the Europe for its Virtis sacral nerve stimulation (SNS) system. Medtronic plc has a dominant share in this market with its strong product portfolio and distribution network. Some of the key players operating in this market are, Axonics Modulation Technologies, Inc, Medtronic plc, Nuvectra Corporation and Cogentix Medical.
Sacral Nerve Stimulation Market Segmentation:
By Product:
- External SNS Devices
- Implantable SNS Devices
By Application:
- Urine Incontinence
- Fecal Incontinence
- Other Applications
By Region:
- North America
- U.S
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- Rest of the World
- Brazil
- South Africa
- Saudi Arabia
- Turkey
- United Arab Emirates
- Others
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2022 to 2027?
- What will be the industry market growth from 2022 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
- Sacral Nerve Stimulation Market, By Product, Estimates and Forecast, 2017-2027 ($Million)
- External SNS Devices
- Implantable SNS Devices
- Sacral Nerve Stimulation Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
- Urine Incontinence
- Fecal Incontinence
- Other Applications
- Sacral Nerve Stimulation Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
- North America
- North America Sacral Nerve Stimulation Market, By Country
- North America Sacral Nerve Stimulation Market, By Product
- North America Sacral Nerve Stimulation Market, By Application
- U.S. Sacral Nerve Stimulation Market, By Product
- U.S. Sacral Nerve Stimulation Market, By Application
- Canada Sacral Nerve Stimulation Market, By Product
- Canada Sacral Nerve Stimulation Market, By Application
- Mexico Sacral Nerve Stimulation Market, By Product
- Mexico Sacral Nerve Stimulation Market, By Application
-
- Europe
- Europe Sacral Nerve Stimulation Market, By Country
- Europe Sacral Nerve Stimulation Market, By Product
- Europe Sacral Nerve Stimulation Market, By Application
- Germany Sacral Nerve Stimulation Market, By Product
- Germany Sacral Nerve Stimulation Market, By Application
- France Sacral Nerve Stimulation Market, By Product
- France Sacral Nerve Stimulation Market, By Application
- UK Sacral Nerve Stimulation Market, By Product
- UK Sacral Nerve Stimulation Market, By Application
- Italy Sacral Nerve Stimulation Market, By Product
- Italy Sacral Nerve Stimulation Market, By Application
- Spain Sacral Nerve Stimulation Market, By Product
- Spain Sacral Nerve Stimulation Market, By Application
- Rest of Europe Sacral Nerve Stimulation Market, By Product
- Rest of Europe Sacral Nerve Stimulation Market, By Application
-
- Asia-Pacific
- Asia-Pacific Sacral Nerve Stimulation Market, By Country
- Asia-Pacific Sacral Nerve Stimulation Market, By Product
- Asia-Pacific Sacral Nerve Stimulation Market, By Application
- Japan Sacral Nerve Stimulation Market, By Product
- Japan Sacral Nerve Stimulation Market, By Application
- Australia Sacral Nerve Stimulation Market, By Product
- Australia Sacral Nerve Stimulation Market, By Application
- India Sacral Nerve Stimulation Market, By Product
- India Sacral Nerve Stimulation Market, By Application
- South Korea Sacral Nerve Stimulation Market, By Product
- South Korea Sacral Nerve Stimulation Market, By Application
- Rest of Asia-Pacific Sacral Nerve Stimulation Market, By Product
- Rest of Asia-Pacific Sacral Nerve Stimulation Market, By Application
- Asia-Pacific
-
- Rest of the World
- Rest of the World Sacral Nerve Stimulation Market, By Country
- Rest of the World Sacral Nerve Stimulation Market, By Product
- Rest of the World Sacral Nerve Stimulation Market, By Application
- Brazil Sacral Nerve Stimulation Market, By Product
- Brazil Sacral Nerve Stimulation Market, By Application
- South Africa Sacral Nerve Stimulation Market, By Product
- South Africa Sacral Nerve Stimulation Market, By Application
- Saudi Arabia Sacral Nerve Stimulation Market, By Product
- Saudi Arabia Sacral Nerve Stimulation Market, By Application
- Turkey Sacral Nerve Stimulation Market, By Product
- Turkey Sacral Nerve Stimulation Market, By Application
- United Arab Emirates Sacral Nerve Stimulation Market, By Product
- United Arab Emirates Sacral Nerve Stimulation Market, By Application
- Others Sacral Nerve Stimulation Market, By Product
- Others Sacral Nerve Stimulation Market, By Application
- Rest of the World
Table of Contents
1.Introduction
1.1.Report Description
1.2.Research Methodology
1.2.1. Secondary Research
1.2.2. Primary Research
2.Executive Summary
2.1.Key Highlights
3.Market Overview
3.1.Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2.Market Share Analysis
3.3.Market Dynamics
3.3.1. Drivers
3.3.1.1.Increasing Incidence of OAB Conditions Around the World
3.3.1.2.Rising Geriatric Population Globally
3.3.1.3.Increasing Investments in Development of SNS Devices
3.3.2. Restraints
3.3.2.1.Side-effects Associated with SNS Devices
3.3.2.2.Unfavorable Reimbursement Policies
3.3.3. Opportunities
3.3.3.1.Emerging Markets to Offer Lucrative Growth Opportunities
3.4.Industry Trends
4.Sacral Nerve Stimulation Market, By Product
4.1.Introduction
4.2.Sacral Nerve Stimulation Market Assessment and Forecast, By Product, 2017-2027
4.3.External SNS Devices
4.3.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.4.Implantable SNS Devices
4.4.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
5.Sacral Nerve Stimulation Market, By Application
5.1.Introduction
5.2.The Sacral Nerve Stimulation Market Assessment and Forecast, By Application, 2017-2027
5.3.Urine Incontinence
5.3.1.1.Market Assessment and Forecast, By Region, 2017-2027 ($Million)
5.4.Fecal Incontinence
5.4.1.1.Market Assessment and Forecast, By Region, 2017-2027 ($Million)
5.5.Other Applications
5.5.1.1.Market Assessment and Forecast, By Region, 2017-2027 ($Million)
6.Sacral Nerve Stimulation Market, By Region
6.1.Introduction
6.2.Sacral Nerve Stimulation Market Assessment and Forecast, By Region, 2017-2027 ($Million)
6.3.North America
6.3.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)
6.3.2. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.3.3. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.3.4. U.S.
6.3.4.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.3.4.2.Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.3.5. Canada
6.3.5.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.3.5.2.Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.3.6. Mexico
6.3.6.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.3.6.2.Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.4.Europe
6.4.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)
6.4.2. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.4.3. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.4.4. Germany
6.4.4.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.4.4.2.Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.4.5. France
6.4.5.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.4.5.2.Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.4.6. UK
6.4.6.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.4.6.2.Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.4.7. Italy
6.4.7.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.4.7.2.Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.4.8. Spain
6.4.8.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.4.8.2.Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.4.9. Russia
6.4.9.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.4.9.2.Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.4.10.Rest of Europe
6.4.10.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.4.10.2.Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.5.Asia-Pacific
6.5.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)
6.5.2. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.5.3. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.5.4. Japan
6.5.4.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.5.4.2.Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.5.5. China
6.5.5.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.5.5.2.Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.5.6. Australia
6.5.6.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.5.6.2.Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.5.7. India
6.5.7.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.5.7.2.Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.5.8. South Korea
6.5.8.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.5.8.2.Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.5.9. Taiwan
6.5.9.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.5.9.2.Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.5.10.Rest of Asia-Pacific
6.5.10.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.5.10.2.Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.6.Rest of the World
6.6.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)
6.6.2. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.6.3. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.6.4. Brazil
6.6.4.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.6.4.2.Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.6.5. Turkey
6.6.5.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.6.5.2.Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.6.6. Saudi Arabia
6.6.6.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.6.6.2.Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.6.7. South Africa
6.6.7.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.6.7.2.Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.6.8. United Arab Emirates
6.6.8.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.6.8.2.Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.6.9. Others
6.6.9.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.6.9.2.Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.Company Profiles
7.1.Axonics Modulation Technologies, Inc
7.1.1. Business Overview
7.1.2. Product Portfolio
7.1.3. Strategic Developments
7.2.Medtronic plc
7.2.1. Business Overview
7.2.2. Product Portfolio
7.2.3. Key Financials
7.2.4. Strategic Developments
7.3.Nuvectra Corporation
7.3.1. Business Overview
7.3.2. Product Portfolio
7.3.3. Key Financials
7.3.4. Strategic Developments
7.4.Cogentix Medical
7.4.1. Business Overview
7.4.2. Product Portfolio
7.4.3. Key Financials
7.4.4. Strategic Developments
List of Tables
Table 1.Global Sacral Nerve Stimulation Market, By Product ($Million), 2017-2025
Table 2.External SNS Devices Market, By Region ($Million), 2017-2025
Table 3.Implantable SNS Devices Market, By Region ($Million), 2017-2025
Table 4.Global Sacral Nerve Stimulation Market, By Application ($Million), 2017-2025
Table 5.Urine Incontinence Market, By Region ($Million), 2017-2025
Table 6.Fecal Incontinence Market, By Region ($Million), 2017-2025
Table 7.Other Applications Market, By Region ($Million), 2017-2025
Table 8.Sacral Nerve Stimulation Market, By Region ($Million), 2017-2025
Table 9.North America Sacral Nerve Stimulation Market, By Country, 2017-2025 ($Million)
Table 10.North America Sacral Nerve Stimulation Market, By Product, 2017-2025 ($Million)
Table 11.North America Sacral Nerve Stimulation Market, By Application, 2017-2025 ($Million)
Table 12.U.S. Sacral Nerve Stimulation Market, by Product, 2017-2025 ($Million)
Table 13.U.S. Sacral Nerve Stimulation Market, by Application, 2017-2025 ($Million)
Table 14.Canada Sacral Nerve Stimulation Market, By Product, 2017-2025 ($Million)
Table 15.Canada Sacral Nerve Stimulation Market, By Application, 2017-2025 ($Million)
Table 16.Mexico Sacral Nerve Stimulation Market, By Product, 2017-2025 ($Million)
Table 17.Mexico Sacral Nerve Stimulation Market, By Application, 2017-2025 ($Million)
Table 18.Europe Sacral Nerve Stimulation Market, By Country, 2017-2025 ($Million)
Table 19.Europe Sacral Nerve Stimulation Market, By Product, 2017-2025 ($Million)
Table 20.Europe Sacral Nerve Stimulation Market, By Application, 2017-2025 ($Million)
Table 21.Germany Sacral Nerve Stimulation Market, By Product, 2017-2025 ($Million)
Table 22.Germany Sacral Nerve Stimulation Market, By Application, 2017-2025 ($Million)
Table 23.France Sacral Nerve Stimulation Market, By Product, 2017-2025 ($Million)
Table 24.France Sacral Nerve Stimulation Market, By Application, 2017-2025 ($Million)
Table 25.UK Sacral Nerve Stimulation Market, By Product, 2017-2025 ($Million)
Table 26.UK Sacral Nerve Stimulation Market, By Application, 2017-2025 ($Million)
Table 27.Italy Sacral Nerve Stimulation Market, By Product, 2017-2025 ($Million)
Table 28.Italy Sacral Nerve Stimulation Market, By Application, 2017-2025 ($Million)
Table 29.Spain Sacral Nerve Stimulation Market, By Product, 2017-2025 ($Million)
Table 30.Spain Sacral Nerve Stimulation Market, By Application, 2017-2025 ($Million)
Table 31.Russia Sacral Nerve Stimulation Market, By Product, 2017-2025 ($Million)
Table 32.Russia Sacral Nerve Stimulation Market, By Application, 2017-2025 ($Million)
Table 33.Rest of Europe Sacral Nerve Stimulation Market, By Product, 2017-2025 ($Million)
Table 34.Rest of Europe Sacral Nerve Stimulation Market, By Application, 2017-2025 ($Million)
Table 35.Asia-Pacific Sacral Nerve Stimulation Market, By Country, 2017-2025 ($Million)
Table 36.Asia-Pacific Sacral Nerve Stimulation Market, By Product, 2017-2025 ($Million)
Table 37.Asia-Pacific Sacral Nerve Stimulation Market, By Application, 2017-2025 ($Million)
Table 38.Japan Sacral Nerve Stimulation Market, By Product, 2017-2025 ($Million)
Table 39.Japan Sacral Nerve Stimulation Market, By Application, 2017-2025 ($Million)
Table 40.China Sacral Nerve Stimulation Market, By Product, 2017-2025 ($Million)
Table 41.China Sacral Nerve Stimulation Market, By Application, 2017-2025 ($Million)
Table 42.Australia Sacral Nerve Stimulation Market, By Product, 2017-2025 ($Million)
Table 43.Australia Sacral Nerve Stimulation Market, By Application, 2017-2025 ($Million)
Table 44.India Sacral Nerve Stimulation Market, By Product, 2017-2025 ($Million)
Table 45.India Sacral Nerve Stimulation Market, By Application, 2017-2025 ($Million)
Table 46.South Korea Sacral Nerve Stimulation Market, By Product, 2017-2025 ($Million)
Table 47.South Korea Sacral Nerve Stimulation Market, By Application, 2017-2025 ($Million)
Table 48.Taiwan Sacral Nerve Stimulation Market, By Product, 2017-2025 ($Million)
Table 49.Taiwan Sacral Nerve Stimulation Market, By Application, 2017-2025 ($Million)
Table 50.Rest of Asia-Pacific Sacral Nerve Stimulation Market, By Product, 2017-2025 ($Million)
Table 51.Rest of Asia-Pacific Sacral Nerve Stimulation Market, By Application, 2017-2025 ($Million)
Table 52.Rest of the World Sacral Nerve Stimulation Market, By Country, 2017-2025 ($Million)
Table 53.Rest of the World Sacral Nerve Stimulation Market, By Product, 2017-2025 ($Million)
Table 54.Rest of the World Sacral Nerve Stimulation Market, By Application, 2017-2025 ($Million)
Table 55.Brazil Sacral Nerve Stimulation Market, By Product, 2017-2025 ($Million)
Table 56.Brazil Sacral Nerve Stimulation Market, By Application, 2017-2025 ($Million)
Table 57.Turkey Sacral Nerve Stimulation Market, By Product, 2017-2025 ($Million)
Table 58.Turkey Sacral Nerve Stimulation Market, By Application, 2017-2025 ($Million)
Table 59.Saudi Arabia Sacral Nerve Stimulation Market, By Product, 2017-2025 ($Million)
Table 60.Saudi Arabia Sacral Nerve Stimulation Market, By Application, 2017-2025 ($Million)
Table 61.South Africa Sacral Nerve Stimulation Market, By Product, 2017-2025 ($Million)
Table 62.South Africa Sacral Nerve Stimulation Market, By Application, 2017-2025 ($Million)
Table 63.United Arab Emirates Sacral Nerve Stimulation Market, By Product, 2017-2025 ($Million)
Table 64.United Arab Emirates Sacral Nerve Stimulation Market, By Application, 2017-2025 ($Million)
Table 65.Others Sacral Nerve Stimulation Market, By Product, 2017-2025 ($Million)
Table 66.Others Sacral Nerve Stimulation Market, By Application, 2017-2025 ($Million)
Table 67.Axonics Modulation Technologies, Inc.: Key Strategic Developments, 2017-2017
Table 68.Medtronic plc: Key Strategic Developments, 2017-2017
Table 69.Nuvectra Corporation: Key Strategic Developments, 2017-2017
Table 70.Cogentix Medical: Key Strategic Developments, 2017-2017
List of Figures
Figure 1.Global Sacral Nerve Stimulation Market Share, By Product, 2017 & 2025
Figure 2.Sacral Nerve Stimulation Market, By Application, 2017, ($Million)
Figure 3.Sacral Nerve Stimulation Market, By Region, 2017, ($Million)
Figure 4.Medtronic plc: Net Revenues, 2017-2017 ($Million)
Figure 5.Medtronic plc: Net Revenue Share, By Segment, 2017
Figure 6.Medtronic plc: Net Revenue Share, By Geography, 2017
Figure 7.Nuvectra Corporation: Net Revenues, 2017-2017 ($Million)
Figure 8.Nuvectra Corporation: Net Revenue Share, By Segment, 2017
Figure 9.Nuvectra Corporation: Net Revenue Share, By Geography, 2017
Figure 10.Cogentix Medical: Net Revenues, 2017-2017 ($Million)
Figure 11.Cogentix Medical: Net Revenue Share, By Segment, 2017
Figure 12.Cogentix Medical: Net Revenue Share, By Geography, 2017
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|